Interscalene Bupivacaine With Either Liposomal Bupivacaine or Continuous Peripheral Nerve Block for Shoulder Arthroscopy

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 11, 2019

Primary Completion Date

December 12, 2022

Study Completion Date

December 30, 2022

Conditions
Shoulder Pain
Interventions
PROCEDURE

Single-injection bupivacaine HCl plus liposomal bupivacaine

Patients in the liposomal bupivacaine with added bupivacaine HCl ISB group will be given a single injection LB ISB in the preoperative area only by faculty who are part of the regional anesthesia division. The injectate will include liposomal bupivacaine 10ml (133mg) mixed with bupivacaine HCl 0.5% 10 ml.

PROCEDURE

Single-injection bupivacaine HCl plus a subsequent bupivacaine CISB

Patients in the bupivacaine CISB group will undergo catheter placement with ultrasound guidance only by faculty who are part of the regional anesthesia division. A 20 mL single bolus ISB with 0.25% bupivacaine will be administered followed by catheter infusion of 0.125% bupivacaine at a rate of 5mL/hour postoperatively by the ON-Q pump

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT03816982 - Interscalene Bupivacaine With Either Liposomal Bupivacaine or Continuous Peripheral Nerve Block for Shoulder Arthroscopy | Biotech Hunter | Biotech Hunter